Using a novel in silico screening method MIGWAS, Yukinori Okada (Graduate School of Medicine, Osaka University and IFReC) and his research group showed that miRNA-target gene network contributes to human disease genetics in a cell type-specific manner, which could yield an efficient screening of miRNAs as promising biomarkers.

Concept of a novel in silico screening method MIGWAS,
which integrates genetics and miRNA-target gene network.

Commentary(PDF)


Article (External Link)

Contact:

Yukinori Okada（Statistical Immunology）

+81-6-6879-3971
yokadasg.med.osaka-u.ac.jp

Immunology Frontier Research Center, Osaka University (WPI-IFReC)